MedTrace Logo

Remimazolam vs. Propofol: Impact on Postoperative Delirium in Neurosurgical Patients

NCT06115031 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 696

Last updated 2024-04-17

No results posted yet for this study

Summary

The investigator aimed to evaluate the incidence of postoperative delirium after remimazolam-based total intravenous anestheisa (TIVA) compared to the propofol-based TIVA in patients undergoing neurosurgery.

Conditions

  • Postoperative Delirium

Interventions

DRUG

Remimazolam

General anesthesia will be induced and maintained using continuous infusion of intravenous remimazolam.

DRUG

Propofol

General anesthesia will be induced and maintained using target-controlled infusion of intravenous propofol.

Sponsors & Collaborators

  • Samsung Medical Center

    lead OTHER

Principal Investigators

  • Jiseon jeong · Samsung Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-29
Primary Completion
2025-12-31
Completion
2026-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06115031 on ClinicalTrials.gov